Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting type I interferons in systemic lupus erythematous
Sebastian Bruera, Thandiwe Chavula, Riya Madan, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 22

Showing 22 citing articles:

Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
Angel A Justiz-Vaillant, Darren Gopaul, Sachin Soodeen, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 747-747
Open Access | Times Cited: 26
Aicardi–Goutières syndrome: A monogenic type I interferonopathy
Anran Liu, Songcheng Ying
Scandinavian Journal of Immunology (2023) Vol. 98, Iss. 4
Open Access | Times Cited: 22
“Input/output cytokines” in epidermal keratinocytes and the involvement in inflammatory skin diseases
Shin Morizane, Tomoyuki Mukai, Ko Sunagawa, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Signaling by Type I Interferons in Immune Cells: Disease Consequences
Μαρκέλλα Ζαννίκου, Eleanor N. Fish, Leonidas C. Platanias
Cancers (2024) Vol. 16, Iss. 8, pp. 1600-1600
Open Access | Times Cited: 5
A glance on the role of IL-35 in systemic lupus erythematosus (SLE)
Davood Bahadorian, Tola Abdulsattar Faraj, Ramiar Kamal Kheder, et al.
Cytokine (2024) Vol. 176, pp. 156501-156501
Closed Access | Times Cited: 4
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus
Vincent Hurez, Glenn Gauderat, Perrine Soret, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111754-111754
Open Access
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
Kristoffer A. Zervides, Elsa Grenmyr, Shorena Janelidze, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
An Integrative Mechanistic Model of Type 1 IFN‐Mediated Inflammation in Systemic Lupus Erythematosus
Alina Volkova, Victor Sokolov, Florencia A. T. Boshier, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis
Eleni Moysidou, Michalis Christodoulou, Γεώργιος Λιούλιος, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10905-10905
Open Access | Times Cited: 3
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Stanley M. Cohen, Jean S. Beebe, Vishala Chindalore, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options
Konstantinos Drougkas, Charalampos Skarlis, Clio P. Mavragani
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. Suppl 2, pp. 365-365
Open Access | Times Cited: 2
Interferon Inhibition in SLE: From Bench to Bedside
Dimitrios Deligeorgakis, Elpida Skouvaklidou, Christina Adamichou
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. Suppl 2, pp. 354-354
Open Access | Times Cited: 2
New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review
Yuya Sumichika, Jumpei Temmoku, Kenji Saito, et al.
Internal Medicine (2024) Vol. 63, Iss. 10, pp. 1491-1498
Open Access | Times Cited: 1
Positionally distinct interferon stimulated dermal immune acting fibroblasts promote neutrophil recruitment in Sweet's syndrome
Kellen Cavagnero, Julie Albright, Fengwu Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis
Szabina Erdő-Bonyár, Judit Rapp, Rovéna Subicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7933-7933
Open Access | Times Cited: 1
Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications
Mads Lamm Larsen, Morten Kelder Skouboe, Trine H. Mogensen, et al.
American Journal of Case Reports (2024) Vol. 25
Open Access | Times Cited: 1
Targeting the Type I IFN Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
James A. Tumlin, Brad H. Rovin, Hans‐Joachim Anders, et al.
Kidney International Reports (2024) Vol. 10, Iss. 1, pp. 29-39
Open Access | Times Cited: 1
Interferon-Inhibition beim systemischen Lupus erythematodes
Johanna Mücke
Arthritis und Rheuma (2024) Vol. 44, Iss. 02, pp. 95-100
Closed Access
Insights into the genetic landscape of systemic sclerosis
Ali El-Halwagi, Sandeep K. Agarwal
Best Practice & Research Clinical Rheumatology (2024), pp. 101981-101981
Closed Access
Comprehensive Insights into Neuropsychiatric Systemic Lupus Erythematosus
Monika Turek, Klara Wojciechowska, Karolina Piątkowska, et al.
Quality in Sport (2024) Vol. 18, pp. 53423-53423
Open Access
Innovation in Dermatomyositis
Kimberly B. Hashemi, Katharina S. Shaw, Rochelle Castillo, et al.
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 103-110
Closed Access
The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back
António Lamas, Raquel Faria, António Marinho, et al.
Autoimmunity Reviews (2024), pp. 103675-103675
Closed Access
Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study
Marta Mosca, Cathy Emmas, Cassandra Nan, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e086055-e086055
Open Access
Page 1

Scroll to top